In a report released on January 7, Gregory Renza from RBC Capital maintained a Buy rating on MannKind (MNKD – Research Report), with a price target of $10.00. The company’s shares closed last ...

MannKind (NASDAQ:MNKD) Corporation (NASDAQ:MNKD), a biopharmaceutical company with a market capitalization of $1.76 billion and impressive revenue growth of 51% over the last twelve months ...

Get Our Latest Stock Analysis on MNKD MannKind Price Performance MannKind stock opened at $7.02 on Monday. The company has a market cap of $1.94 billion, a PE ratio of 100.29 and a beta of 1.28 ...

and WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focusing on the development and commercialization of innovative inhaled therapeutic ...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focusing on the development and commercialization of innovative ...

MannKind (NASDAQ:MNKD) Corporation (NASDAQ:MNKD), a biopharmaceutical company with a market capitalization of $1.76 billion and impressive revenue growth of 51% over the last twelve months, announced ...

Lauren Sabella has announced her intention to retire from MannKind Corporation, effective July 18, 2025. She has been appointed as Executive Vice President, Operations, effective January 6 ...

In other cases, you may need to bring in stronger reinforcements. Enter: the foot mask. “Foot masks are designed to hydrate and soften the skin, and, in some cases, offer exfoliation,” Dr ...